JP7216638B2 - 増強された蛍光のための組成物および方法 - Google Patents

増強された蛍光のための組成物および方法 Download PDF

Info

Publication number
JP7216638B2
JP7216638B2 JP2019512260A JP2019512260A JP7216638B2 JP 7216638 B2 JP7216638 B2 JP 7216638B2 JP 2019512260 A JP2019512260 A JP 2019512260A JP 2019512260 A JP2019512260 A JP 2019512260A JP 7216638 B2 JP7216638 B2 JP 7216638B2
Authority
JP
Japan
Prior art keywords
antibody
peg
alexa fluor
spacer
dylight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019512260A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019531474A5 (https=
JP2019531474A (ja
Inventor
サービ デサイ
マリー ナレンド
カイル ギー
マシュー ベイカー
ロバート アグジェラー
スコット スウィーニー
アレクシー ルカビシュニコブ
シー－ジュン ファン
Original Assignee
ライフ テクノロジーズ コーポレーション
ピアス・バイオテクノロジー・インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライフ テクノロジーズ コーポレーション, ピアス・バイオテクノロジー・インコーポレイテッド filed Critical ライフ テクノロジーズ コーポレーション
Publication of JP2019531474A publication Critical patent/JP2019531474A/ja
Publication of JP2019531474A5 publication Critical patent/JP2019531474A5/ja
Priority to JP2022179386A priority Critical patent/JP2023025018A/ja
Application granted granted Critical
Publication of JP7216638B2 publication Critical patent/JP7216638B2/ja
Priority to JP2024196507A priority patent/JP2025028883A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0015—Phosphorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Electroluminescent Light Sources (AREA)
JP2019512260A 2016-09-01 2017-09-01 増強された蛍光のための組成物および方法 Active JP7216638B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022179386A JP2023025018A (ja) 2016-09-01 2022-11-09 増強された蛍光のための組成物および方法
JP2024196507A JP2025028883A (ja) 2016-09-01 2024-11-11 増強された蛍光のための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662382594P 2016-09-01 2016-09-01
US62/382,594 2016-09-01
PCT/US2017/049838 WO2018045278A1 (en) 2016-09-01 2017-09-01 Compositions and methods for enhanced fluorescence

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022179386A Division JP2023025018A (ja) 2016-09-01 2022-11-09 増強された蛍光のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2019531474A JP2019531474A (ja) 2019-10-31
JP2019531474A5 JP2019531474A5 (https=) 2020-10-15
JP7216638B2 true JP7216638B2 (ja) 2023-02-01

Family

ID=59846737

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019512260A Active JP7216638B2 (ja) 2016-09-01 2017-09-01 増強された蛍光のための組成物および方法
JP2022179386A Pending JP2023025018A (ja) 2016-09-01 2022-11-09 増強された蛍光のための組成物および方法
JP2024196507A Pending JP2025028883A (ja) 2016-09-01 2024-11-11 増強された蛍光のための組成物および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022179386A Pending JP2023025018A (ja) 2016-09-01 2022-11-09 増強された蛍光のための組成物および方法
JP2024196507A Pending JP2025028883A (ja) 2016-09-01 2024-11-11 増強された蛍光のための組成物および方法

Country Status (6)

Country Link
US (4) US20180092993A1 (https=)
EP (2) EP3507603B1 (https=)
JP (3) JP7216638B2 (https=)
CN (1) CN109844538A (https=)
ES (1) ES2979129T3 (https=)
WO (1) WO2018045278A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3019559A4 (en) 2013-08-22 2017-04-05 Sony Corporation Water soluble fluorescent or colored dyes and methods for their use
AU2017240154B2 (en) 2016-04-01 2021-08-12 Sony Group Corporation Ultra bright dimeric or polymeric dyes
US9851359B2 (en) 2016-04-06 2017-12-26 Sony Corporation Of America Ultra bright dimeric or polymeric dyes with spacing linker groups
KR102526802B1 (ko) 2016-05-11 2023-05-02 소니그룹주식회사 초고명도 이량체성 또는 중합체성 염료
JP7312929B2 (ja) 2016-07-29 2023-07-24 ソニーグループ株式会社 超明色二量体またはポリマー色素およびその調製のための方法
EP3507603B1 (en) * 2016-09-01 2024-03-06 Life Technologies Corporation Compositions and methods for enhanced fluorescence
JP7270254B2 (ja) 2017-06-16 2023-05-10 デューク ユニバーシティ 改善された標識検出、演算、検体感知、および調整可能な乱数生成のための共鳴体ネットワーク
CN111093711A (zh) 2017-10-05 2020-05-01 索尼公司 可编程的树枝状药物
JP7551056B2 (ja) 2017-10-05 2024-09-17 ソニーグループ株式会社 プログラマブルなポリマー薬物
CN111836645A (zh) 2017-11-16 2020-10-27 索尼公司 可编程的聚合药物
US20190154669A1 (en) * 2017-11-20 2019-05-23 Vector Laboratories, Inc. Methods and systems for species-on-species immunoassay detection
CN111565756A (zh) 2018-01-12 2020-08-21 索尼公司 包含生物活性化合物的具有刚性间隔基团的聚合物
US12194104B2 (en) 2018-01-12 2025-01-14 Sony Group Corporation Phosphoalkyl ribose polymers comprising biologically active compounds
EP3737419B1 (en) 2018-01-12 2024-04-10 Sony Group Corporation Phosphoalkyl polymers comprising biologically active compounds
US11874280B2 (en) 2018-03-19 2024-01-16 Sony Group Corporation Use of divalent metals for enhancement of fluorescent signals
KR102864292B1 (ko) 2018-03-21 2025-09-26 소니그룹주식회사 링커 군을 갖는 중합체성 텐덤 염료
CN119220109A (zh) 2018-03-30 2024-12-31 贝克顿·迪金森公司 含侧基发色团的水溶性聚合染料
US12006438B2 (en) 2018-06-27 2024-06-11 Sony Group Corporation Polymeric dyes with linker groups comprising deoxyribose
CN109086566B (zh) * 2018-07-12 2021-06-18 浙江工业大学 一种基于片段重采样的群体蛋白质结构预测方法
EP3820944A1 (en) 2018-07-13 2021-05-19 Sony Corporation Polymeric dyes having a backbone comprising organophosphate units
JP2022533145A (ja) * 2019-05-13 2022-07-21 シャンハイ ポラリス バイオロジー カンパニー， リミテッド 生体分子を標識するためのタグ
US20220229047A1 (en) * 2019-06-20 2022-07-21 Konica Minolta, Inc. Linked body for fluorescent labeling agents
WO2021062176A2 (en) 2019-09-26 2021-04-01 Sony Corporation Polymeric tandem dyes with linker groups
EP4038081A1 (en) 2019-09-30 2022-08-10 Sony Group Corporation Nucleotide probes
CN115023611A (zh) * 2020-03-25 2022-09-06 积水医疗株式会社 免疫学分析方法和免疫学分析试剂盒
CN113913404B (zh) * 2020-07-10 2025-08-12 上海米然生物科技有限公司 一种荧光交联RNase H突变体缀合物及其应用
US11408825B2 (en) 2020-08-28 2022-08-09 Hong Kong Applied Science and Technology Research Institute Company Limited Forensic detector and the system thereof
US12203914B2 (en) 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
WO2022125564A1 (en) 2020-12-07 2022-06-16 Sony Group Corporation Spacing linker group design for brightness enhancement in dimeric or polymeric dyes
CN117642413A (zh) * 2021-08-31 2024-03-01 富士胶片株式会社 化合物及使用了该化合物的标记生物物质
CN116148462B (zh) * 2021-11-22 2025-11-18 菲鹏生物股份有限公司 一种捕获法检测抗体的方法和应用
CN115466960B (zh) * 2022-09-15 2023-05-26 河北工业大学 一种含苯并噻唑基团改性聚天冬氨酸荧光缓蚀剂的制备方法和应用
WO2025182762A1 (ja) * 2024-02-29 2025-09-04 富士レビオ株式会社 検出方法、並びに、これに用いる標識体及びキット
WO2025230756A1 (en) * 2024-05-01 2025-11-06 BioLegend, Inc. Compositions for use with multiple fluorophores and methods of using

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010529186A (ja) 2007-06-14 2010-08-26 イノーバ・バイオサイエンシズ・リミテッド 共役物の製造の改良または共役物の製造
JP2012026879A (ja) 2010-07-23 2012-02-09 Konica Minolta Holdings Inc 蛍光標識剤、並びにこれを用いた結合体及びバイオアッセイ法
US20140206099A1 (en) 2012-09-18 2014-07-24 Biotium, Inc. Methods, compositions and kits for labeling of proteins
JP2015504943A (ja) 2011-12-23 2015-02-16 ゼネラル・エレクトリック・カンパニイ 高密度蛍光色素クラスター

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459272A (en) 1990-10-16 1995-10-17 Research Corporation Technologies Quinoline-2-(carboxaldehyde) reagents for detection of primary amines
AU2002306620A1 (en) 2001-02-28 2002-09-12 Stratagene Fluorescent dye
US6972326B2 (en) 2001-12-03 2005-12-06 Molecular Probes, Inc. Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes
ATE343789T1 (de) * 2002-06-03 2006-11-15 Pamgene Bv Biomolekulares kinetik-messverfahren mit hilfe von einem durchfluss-mikroarray
CN1863549A (zh) * 2003-08-08 2006-11-15 费森尤斯卡比德国有限公司 通过肟连接基团进行连接的聚合物和蛋白质的缀合物
WO2007120762A2 (en) * 2006-04-14 2007-10-25 Cambrios Technologies Corporation Fluorescent particles bound to multifunctional scaffolds and their uses
WO2008017122A1 (en) 2006-08-11 2008-02-14 Starpharma Pty Ltd Polylysine dendrimer contrast agent
US8609423B2 (en) * 2007-05-18 2013-12-17 Life Technologies Corporation Rapid protein labeling and analysis
US9097667B2 (en) * 2007-12-14 2015-08-04 Biotium, Inc. Fluorescent compounds
JP6073684B2 (ja) * 2010-01-19 2017-02-01 シリゲン セカンド リミテッド 指向性バイオマーカーシグナル増幅のための新規の試薬
US9448173B2 (en) 2011-03-08 2016-09-20 The Board Of Trustees Of The University Of Illinois Dye-conjugated dendrimers
WO2013033476A1 (en) 2011-08-30 2013-03-07 Quanta Biodesign, Ltd. Branched discrette peg constructs
AU2013229631B2 (en) 2012-03-05 2017-09-14 Bracco Imaging Spa Dynamic Contrast Enhanced MRI method and agents for the assessment of the macromolecular transport within pathologic tissues
CN102692508B (zh) * 2012-04-28 2014-12-17 广州鸿琪光学仪器科技有限公司 一种快速定量检测肌钙蛋白t的免疫荧光试纸条组件及其制成的检测卡组件和制备方法
WO2014138186A1 (en) * 2013-03-05 2014-09-12 The Johns Hopkins University Bioorthogonal two-component delivery systems for enhanced internalization of nanotherapeutics
US9670318B2 (en) 2015-05-28 2017-06-06 Miltenyi Biotec Gmbh Bright fluorochromes based on multimerization of fluorescent dyes
EP3507603B1 (en) * 2016-09-01 2024-03-06 Life Technologies Corporation Compositions and methods for enhanced fluorescence
CN109640722B (zh) 2016-09-01 2022-05-06 耐克创新有限合伙公司 通风服装

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010529186A (ja) 2007-06-14 2010-08-26 イノーバ・バイオサイエンシズ・リミテッド 共役物の製造の改良または共役物の製造
JP2012026879A (ja) 2010-07-23 2012-02-09 Konica Minolta Holdings Inc 蛍光標識剤、並びにこれを用いた結合体及びバイオアッセイ法
JP2015504943A (ja) 2011-12-23 2015-02-16 ゼネラル・エレクトリック・カンパニイ 高密度蛍光色素クラスター
US20140206099A1 (en) 2012-09-18 2014-07-24 Biotium, Inc. Methods, compositions and kits for labeling of proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KUNTSON, S. et al.，Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer，PLOS ONE，2016年06月23日，Vol.11, No.6, e0157762，pp.1-25

Also Published As

Publication number Publication date
EP3507603B1 (en) 2024-03-06
US20200261602A1 (en) 2020-08-20
WO2018045278A1 (en) 2018-03-08
JP2023025018A (ja) 2023-02-21
US20240042062A1 (en) 2024-02-08
US20180092993A1 (en) 2018-04-05
EP4425179A2 (en) 2024-09-04
ES2979129T3 (es) 2024-09-24
CN109844538A (zh) 2019-06-04
EP3507603A1 (en) 2019-07-10
US11865191B2 (en) 2024-01-09
US20200330610A1 (en) 2020-10-22
JP2025028883A (ja) 2025-03-05
EP3507603C0 (en) 2024-03-06
US11857643B2 (en) 2024-01-02
EP4425179A3 (en) 2024-12-11
JP2019531474A (ja) 2019-10-31

Similar Documents

Publication Publication Date Title
JP7216638B2 (ja) 増強された蛍光のための組成物および方法
JP7097885B2 (ja) 水溶性ポリマー色素
US10670612B2 (en) Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards
WO2018009581A1 (en) Fluorescent water-solvated conjugated polymers
JP6865584B2 (ja) 化合物の共有結合性コンジュゲーションのためのｍＴＧ基質
EP3481900A1 (en) Blue-excitable water-solvated polymeric dyes
WO2022216449A1 (en) Water-soluble yellow green absorbing dyes
JP2019512573A (ja) ポリフルオレノ［４，５−ｃｄｅ］オキセピンコンジュゲート及び分析物検出方法におけるそれらの使用
ES2542337T3 (es) Direccionamiento y seguimiento de antígenos en células vivas
JP2026071206A (ja) 増強された蛍光のための組成物および方法
CN107406515B (zh) 合成的双表位化合物
CN111393872B (zh) 紫外光激发荧光染料及其应用
US7662920B2 (en) Fluorescent polypeptide complex
EP4155349A1 (en) Water-soluble yellow green absorbing dyes
CN111471686A (zh) 一种靶向p53蛋白的寡核苷酸序列及其衍生探针和应用
EP4267679A1 (en) Water-soluble yellow green absorbing dyes
WO2024129493A1 (en) Sulfonate-containing water-solubilizing peptides

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190304

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20200227

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20200227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200831

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200831

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210901

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220301

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220711

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221109

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20221109

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20221128

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20221222

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20221226

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230116

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230120

R150 Certificate of patent or registration of utility model

Ref document number: 7216638

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250